Photo of TrialNet Chair Dr. Haller and Vice Chair Dr. Evans-Molina on a red background. Layered white text reads TrialNet leadership announcement.
Staff Spotlight
Read more
TrialNet Welcomes New Leaders at Pivotal Moment for Type 1 Diabetes Research
June 1, 2026 – Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to the prevention of type 1 diabetes (T1D), today announced the appointment of Michael Haller, MD, as Chair and Carmella Evans-Molina, MD, PhD, as Vice Chair.
blue border on white background. TrialNet logo and text that reads TrialNet Leadership Announcement
Media Release
Read more
TrialNet Appoints New Leadership at Pivotal Moment for Type 1 Diabetes Research
June 1, 2026 – Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to the prevention of type 1 diabetes, today announced the appointment of Michael Haller, MD, as Chair and Carmella Evans-Molina, MD, PhD, as Vice Chair.
photo montage. Left side shows Ayden restoring a turquoise truck. Right side shows Ayden with mom and sister posing in the turquoise truck
Research Spotlight
Read more
Years ahead of a type 1 diabetes diagnosis: How one family turned time into strength
Ayden Haselhorst, age 17, South Dakota
Ayden Haselhorst’s journey with type 1 diabetes (T1D) began a decade before his diagnosis, when he was first screened by TrialNet for autoantibodies that signal increased risk.
Sign up here to join our mailing list for the latest updates on important T1D research and events, straight to your inbox. You can also find us on Facebook @DiabetesTrialNet.
